Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
Z.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
V.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.282NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.131NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.274NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.235NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.65NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.45NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.165NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.258.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.243NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
R.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.216NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.471NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.420NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
L.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.518NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.551NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.207NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.604NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.111NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.619NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.36.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.23.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.316NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AZ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.436NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.558NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.518NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-17471.2Singapore
B.1.1.368NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.404NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.306NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.328NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.533NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.75.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBHNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BL.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.78NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.9.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.64NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.221.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used